Clinical Trials Directory

Trials / Completed

CompletedNCT04771039

Ocular Manifestations of Inflammatory Bowel Disease

Ocular Manifestations of Chronic Inflammatory Bowel Disease (IBD): Retrospective Study in the Hepato-gastroenterology Department of the Nancy CHRU

Status
Completed
Phase
Study type
Observational
Enrollment
87 (actual)
Sponsor
Central Hospital, Nancy, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Ocular damage is found in the 3rd rank of extra intestinal manifestations (MEI) Potentially serious functional complications (see uveitis and risk of blindness) requiring rapid management Rare uveitis in the literature (0.5% -3%), study on a large sample to assess their prevalence in patients with IBD at the Nancy CHRU and describe all the ocular manifestations that can be found.

Conditions

Interventions

TypeNameDescription
OTHERreason for consultationsearch in medical files for reasons for ophthalmology consultation, functional signs, clinical signs, treatment, characteristics of IBD

Timeline

Start date
2013-01-01
Primary completion
2020-12-01
Completion
2020-12-12
First posted
2021-02-25
Last updated
2021-02-25

Source: ClinicalTrials.gov record NCT04771039. Inclusion in this directory is not an endorsement.